packageAnakinra

anakinra

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Anakinra, an interleukin-1 receptor antagonist, is used to treat rheumatoid arthritis, systemic-onset juvenile idiopathic arthritis, and pericarditis, and has also been used for COVID-19. It is an approved medicine with an authorised product in the European Union, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q415411 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:anakinra
ATC codes:L04AC03
DrugBank:DB00026
Wikidata:Q415411
molar mass:17257.6 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown